EVALUATE THE OUTCOMES OF FRONTALIS SLING SUSPENSION TECHNIQUE USING NYLON 3.0 AND SILICONE ROD TO TREAT PTOSIS
Main Article Content
Abstract
Objective: To evaluate the outcomes of the technique with a frontalis sling suspension using Nylon 3.0 and Silicone rod to treat ptosis. Methods: Patients with ptosis indicated for frontalis sling have been treated at National Eye Hospital from 7/2021 to 9/2022. During this period, patients have been applied the technique with a frontalis sling using Nylon 3.0 and silicone rod. Next, the surgical results have been evaluated after 1 week, 1 month and 3 months. Results: The mean age of the subjects was 20,21 ± 23,29 years. Among 24 eyes, the majority of patients had severe ptosis (66,7%) and there was 33,3% moderate ptosis cases. After surgery 1 week, MRD1 has increased to 3.46±1,1mm. And MRD1 has continued to increase at 1 month and after 3 months surgery MRD1 is 3.75 ± 0.82 mm. Mean palpebral fissure height has increased from 4.96 ± 0.69 mm (before) to 8.63 ± 0.82 mm (after 3 months follow up). After postoperative period, 87.5% of patients showed excellent cosmetic success rate. Conclusion: Using Nylon 3.0 and Silicon for frontalis sling suspension is the effective method in terms of both functional aspect and aesthetic aspect for moderate and severe ptosis.
Article Details
Keywords
Ptosis, frontalis sling, Nylon 3.0, Silicone.
References
2. Jones LT, Quickert MH, Wobig JL. The cure of ptosis by aponeurotic repair. Arch Ophthalmol. 1975;93(8):629-634.
3. Steinkogler FJ, Kuchar A, Huber E, Arocker-Mettinger E. Gore-Tex soft-tissue patch frontalis suspension technique in congenital ptosis and in blepharophimosis-ptosis syndrome. Plast Reconstr Surg. 1993;92(6):1057-1060.
4. Rizvi SAR, Gupta Y, Yousuf S. Evaluation of safety and efficacy of silicone rod in tarsofrontalis sling surgery for severe congenital ptosis. Ophthal Plast Reconstr Surg. 2014;30(1):11-14.
5. Etezad Razavi M, Khalifeh M, Yazdani A. Comparing open and closed techniques of frontalis suspension with silicone rod for the treatment congenital blepharoptosis. Orbit. 2014; 33(2):91-95.